Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease (Q61908019)
Jump to navigation
Jump to search
scientific article published in March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease |
scientific article published in March 2012 |
Statements
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease (English)
Cosimo Prantera
Herbert Lochs
Maria Grimaldi
Maria Lia Scribano
Retic Study Group (Rifaximin-Eir Treatment in Crohn's Disease)